Wedbush Reiterates Outperform on Imax, Maintains $46 Price Target

Benzinga Newsdesk www.benzinga.com Negative 84.2%

Neg 84.2% Neu 0% Pos 0%

Wedbush analyst Alicia Reese reiterates Imax (NYSE:IMAX) with a Outperform and maintains $46 price target.

Comments

No comments yet. Be the first!